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Dear Editor, 
O’Driscoll et al. raise interesting points about our comparison of the National Early Warning Score 
(NEWS) and its modification, NEWS2.1   
1. We did not test NEWS2 in clinical practice, as we used a retrospective validation design, stand-
ard practice when evaluating the potential effects of a scoring system prior to exposure to 
patients. In contrast, the Royal College of Physicians’ NEWS2 changes were neither tested by 
a clinical trial nor evaluated retrospectively prior to introduction, whereas NEWS2 has been 
validated using the same study design as ours.1 We could not test the assumption that NEWS2 
will alter behaviour, nor whether any alteration will change patient outcomes. As NEWS2 did 
not improve prediction of 24-hour mortality in patients with "presumed hypercapnia", we 
found no evidence that NEWS2 better identifies a patient group where a behaviour change 
might change outcomes. 
2. Our paper is entirely relevant to NEWS2. NEWS2 is advocated for use in all patients, and we 
presented data independently for each patient group. The British Thoracic Society recom-
mends that3: “… For most patients with known COPD or other known risk factors for hypercap-
nic respiratory failure … a target saturation range of 88-92% is suggested pending the availa-
bility of blood gas results …” This statement risks confusion about which patients SpO2 Scale 











3. The sensitivity of an early warning score (EWS) must be balanced with the workload gener-
ated. However, workload is dictated by escalation criteria, not the score itself. NEWS2 uses a 
fixed escalation protocol regardless of which SpO2 scale is used. An alternative (as we sug-
gested1) would be to modify the escalation thresholds for specific patient groups.  
4. We strongly caution against extrapolating from a distribution of oxygen saturations to con-
clude that a hospital has unsafe practice, particularly as many patients with documented Type 
2 Respiratory Failure (T2RF) had saturations > 93% recorded on air. 
5. The usual aim of an EWS is to identify patients who are ill or deteriorating. Whether also using 
an EWS to guide oxygen (or any other) therapy is beneficial is unknown. The authors cite a 
guideline, an observational study and a single centre pre-hospital intervention randomized 
trial, none restricted to patients with confirmed hypercapnia, neatly highlighting the gap be-
tween evidence and the NEWS2 recommendations. 
6. Patients with respiratory disease are a high-risk group (irrespective of whether they are at risk 
of T2RF) where we believe patients and clinicians would prefer higher sensitivity. However, 
escalation ‘rules’ for such patients may need to be modified to prevent excessive workload. 
 
7. As hospitals throughout the world use NEWS, the workload and human calculation errors as-
sociated with using paper charts remain relevant.  
 
All studies1,5 to date comparing NEWS with NEWS2 performance suggest the added complexity of 
NEWS2 is unlikely to lead to a significant benefit to patients and might lead to harm. As NEWS2 is now 
mandated by NHS England, prospective monitoring of its implementation must be urgently and care-
fully conducted. 
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